Biopharmaceutical Industry
Real-Time Industrial Classifications

UK Biopharmaceutical Industry

Explore the forefront of biopharmaceutical innovation in the UK, where leading companies are advancing medical solutions from living cells and organisms. Access real-time insights and download our free snapshot report to discover the sector’s impact on the UK economy.

Download our Biopharmaceutical report


Liberation from SIC codes

Real-time data that keeps pace with the emerging economy

Fed up with outdated and unreliable data? Get to know the UK economy in real-time and analyse emerging sectors and innovative companies with the power of The Data City’s AI-powered platform.

What are Biopharmaceuticals?

Biopharmaceuticals are complex medicines made from living cells or organisms that are often produced using cutting-edge methods.

The UK’s biopharma industry includes a wide array of companies and start-ups dedicated to developing innovative medical solutions and therapies. This includes the development of vaccines, research into antibodies and the manufacture of human cells or tissues.

Biopharmaceutical sector summary

Discover real-time data and insights sourced directly from The Data City platform, driven by our innovative Real-Time Industrial Classifications (RTICs). Our RTICs harness the power of web data and machine learning, and are published with industry experts for precision and relevance.

Here are the key facts about the Biopharmaceutical sector. The sector has a turnover of £50.7bn currently, has received £20.0bn of investment and the sector is growing at 3.9% per year.

1,178
COMPANIES CONSIDERED
£50.7bn
TOTAL TURNOVER
71,869
TOTAL EMPLOYEES
£20.0bn
TOTAL INVESTMENT FUNDING
£761.7m
TOTAL INNOVATE UK GRANT FUNDING
3.9%
AVERAGE COMPANY GROWTH PER YEAR

Biopharmaceutical verticals

Our industry data goes deep. See the top verticals and specialisms making waves in the UK Biopharmaceutical industry today.

Our Biopharmaceutical RTIC is made up of 6 individual verticals. The top verticals in this sector include Small Molecules, and Advanced Therapy Medicinal Products (ATMPs). You can find out more about the verticals by downloading our RTIC report, or by signing up for a free trial of The Data City platform.

  • Sector Code Description Records
  • RTIC0083 Biopharmaceutical 1178 companies

    Companies involved in the development and production of innovative medical solutions, including antibodies, vaccines, advanced therapy medicinal products (ATMPs), small molecule therapeutics, and blood and cell products.

    • Biopharmaceutical: Advanced Therapy Medicinal Products (ATMPs)

      Companies engaged in the research and manufacturing of Advanced Therapy Medicinal Products (ATMPs) encompassing cell therapies, tissue engineered products (TEPs), combination products, and gene therapies.

      421 companies
    • Biopharmaceutical: Antibodies

      Companies involved in the research and/or manufacture of polyclonal and monoclonal antibodies as well as antibody fragments.

      226 companies
    • Biopharmaceutical: Blood & Tissue Product

      Companies engaged in the manufacture or research of human cells or tissue products intended for implantation, transplantation, infusion or transfer into a human.

      38 companies
    • Biopharmaceutical: Small Molecules

      Companies involved in the manufacturing and research of small organic compounds with low molecular weight that can be taken orally and easily enter cells to target specific areas within them.

      462 companies
    • Biopharmaceutical: Therapeutic protein

      Companies involved in the manufacturing and research of protein-based drug including recombinant, non-recombinant, blood factors and peptides.

      155 companies
    • Biopharmaceutical: Vaccines

      Companies involved in the manufacutring/research of vaccines such as viral, DNA-based, cell-based, recombinant protein, and cellular vaccines.

      376 companies

Biopharmaceutical industry growth

Based on a growth rate of 3.9%, we expect that this sector could be worth £56.7bn by 2026. Below you can see our forecast of the growth of the sector.

We help policy makers, economists & companies better understand emerging industries

The Data City is a UK-based data provider and SaaS platform focusing on emerging sectors, high growth companies, innovation clusters and investment.

Many of the UK’s leading government departments, local authorities, investment firms and policymakers, use The Data City to gain real-time insights that help drive better investment decisions.

 

If you want a more dynamic and innovative view of your economy, you should definitely consider The Data City
Professor Delma Dwight Director | Midlands Engine Observatory
Through this visual mapping project, Greater Manchester will be able to showcase our success in the digital sector
Andy Burnham | Mayor of Greater Manchester
If you care about technology driven economic growth, you should care about RTICs
Stian Westlake | CEO Royal Statistical Society

Get your free Biopharmaceutical market report 👇

Dig deeper into the UK’s Biopharmaceutical industry with our free snapshot report.

Includes key insights on market size, investment, growth, location and much more. Data updated every month.

Market data for 400+ industries at your fingertips

At The Data City we use AI and real-time data to map emerging sectors and innovative companies.

Our company database of over 5 million active UK companies houses 400+ Real-Time Industrial Classifications (RTICs) built in partnership with leading experts.

Access market insights, sector trends, employee data, growth stats and investment information for the country’s fastest growing industries.

The Data City RTICs screenshot

Discover more with a Free Trial

Keen to dig a little deeper? Sign up for a free trial and get full access our real-time company and sector data.

Sign up for a free trial